Actoplus Met XR (Pioglitazone Hydrochloride / Metformin Hydrochloride) - Published Studies

Published Studies Related to Actoplus Met XR (Pioglitazone / Metformin)

Well-designed clinical trials related to Actoplus Met XR (Pioglitazone / Metformin)

PIOfix-study: effects of pioglitazone/metformin fixed combination in comparison with a combination of metformin with glimepiride on diabetic dyslipidemia. [2011.06]

Effects of pioglitazone and metformin fixed-dose combination therapy on cardiovascular risk markers of inflammation and lipid profile compared with pioglitazone and metformin monotherapy in patients with type 2 diabetes. [2010.12]

Efficacy and safety of pioglitazone/metformin fixed-dose combination therapy compared with pioglitazone and metformin monotherapy in treating patients with T2DM. [2009.12]

Other research related to Actoplus Met XR (Pioglitazone / Metformin)

Effects of pioglitazone and metformin fixed-dose combination therapy on cardiovascular risk markers of inflammation and lipid profile compared with pioglitazone and metformin monotherapy in patients with type 2 diabetes. [2010]

Combined pioglitazone and metformin treatment maintains the beneficial effect of short-term insulin infusion in patients with type 2 diabetes: results from a pilot study. [2009.11.01]

Competact, a fixed combination of pioglitazone and metformin, improves metabolic markers in type 2 diabetes patients with insufficient glycemic control by metformin alone--results from a post-marketing surveillance trial under daily routine conditions. [2009.06]

Monitoring the safety of pioglitazone : results of a prescription-event monitoring study of 12,772 patients in England. [2008]

Other possibly related research studies

[Difference between biguanide and thiazolidinedione, and the significance of combination therapy of biguanide and thiazolidinedione] [2010.05]

Treatment update: thiazolidinediones in combination with metformin for the treatment of type 2 diabetes. [2007]

[Difference between biguanide and thiazolidinedione, and the significance of combination therapy of biguanide and thiazolidinedione]. [2010.05]